SCHEMBL6601983

SCHEMBL6601983

Cc1ncc(C(O[SiH](C)C)C(C)(C)C)n1Cc1ccc2c(c1)OCO2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.45
▸ TSHR P16473 4/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ HSD17B10 Q99714 4/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CASP1 P29466 2/20 0.45
▸ SMN1; SMN2 Q16637 6/20 0.42
▸ LMNA P02545 4/20 0.42
▸ CMA1 P23946 1/20 0.38
▸ PDE1A P54750 2/20 0.37
▸ PDE1B Q01064 2/20 0.37
▸ PDE1C Q14123 2/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPK1 P28482 3/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ALOX15 P16050 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6598800 0.80 PDE5A (0.40) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL6601984 0.72 KDM4E (0.47) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL6598283 0.71 TSHR (0.54) KDM4ETSHRMEN1KMT2AHSD17B10
Hydrochloric Acid SCHEMBL6598041 0.70 TSHR (0.53) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL6601216 0.68 PDE5A (0.40) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL28330025 0.66 TSHR (0.64) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL7506674 0.66 TAAR1 (0.51) MAPTGAACYP3A4CYP2D6SLC6A2
SCHEMBL7508160 0.62 GAA (0.46) HSD17B10MAPTSMN1; SMN2GAACYP3A4
SCHEMBL23193020 0.61 MEN1 (0.75) KDM4ETSHRMEN1KMT2AHSD17B10
SCHEMBL20379522 0.60 TSHR (0.52) KDM4ETSHRMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1169320-B1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2004-09-22 — — EP disclosed
US-6511978-B1 For treating cancer, restenosis, atherosclerosis or viral infections LG LIFE SCIENCES, LTD. (KR) 2003-01-28 — — US disclosed
EP-1169320-A4 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD (KR) 2002-10-30 — — EP disclosed
EP-1169320-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG Chem Investment, Ltd. (KR) 2002-01-09 — — EP disclosed
WO-2000064891-A1 FARNESYL TRANSFERASE INHIBITORS HAVING A PYRROLE STRUCTURE AND PROCESS FOR PREPARATION THEREOF LG CHEM INVESTMENT LTD. (KR) 2000-11-02 — — WO disclosed
Send feedback